Trademark: 87229070
Status Date
Monday, November 5, 2018
Filing Date
Monday, November 7, 2016
Published for Opposition
Tuesday, March 14, 2017
5 Pharmaceutical preparations, namely, breast aesthetic treatment procedures; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma agents and decongestant formulations; sterile antibiotic ointments; ocular contact lens wetting solutions, artificial tears and pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing pharmaceutical preparations; Pharmaceutical preparations and medicines for the treatment and prevention of sexual dysfunction; Pharmaceutical preparations and medicines for the treatment of sensory organ disorders; Pharmaceutical preparations and medicines for the treatment of central nervous system disorders; Pharmaceutical preparations and medicines for the treatment of urogenital organ disorders; Pharmaceutical preparations and medicines for the treatment of circulatory system disorders; Pharmaceutical preparations and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract and gastrointestinal diseases and disorders; Pharmaceutical preparations and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression; neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; none of the above relating to pharmaceutical products for the prevention or treatment of cancer
Nov 5, 2018
Petition To Revive-Denied
Sep 7, 2018
Incomplete Petition Notice Mailed
Sep 7, 2018
Assigned To Petition Staff
Sep 4, 2018
Petition To Revive-Received
Sep 7, 2018
Notice Of Approval Of Extension Request E-Mailed
Sep 6, 2018
Extension 1 Granted
Mar 5, 2018
Extension 1 Filed
Sep 5, 2018
Notice Of Revival - E-Mailed
Sep 4, 2018
Extension Received With Teas Petition
Sep 4, 2018
Petition To Revive-Granted
Sep 4, 2018
Teas Petition To Revive Received
Apr 9, 2018
Abandonment Notice Mailed - No Use Statement Filed
Apr 9, 2018
Abandonment - No Use Statement Filed
Sep 5, 2017
Noa E-Mailed - Sou Required From Applicant
Jul 23, 2017
Extension Of Time To Oppose Process - Terminated
Apr 21, 2017
Changes/Corrections After Pub Approval Entered
Apr 17, 2017
Assigned To Petition Staff
Apr 6, 2017
Teas Post Publication Amendment Received
Mar 27, 2017
Extension Of Time To Oppose Received
Mar 14, 2017
Official Gazette Publication Confirmation E-Mailed
Mar 14, 2017
Published For Opposition
Feb 22, 2017
Notification Of Notice Of Publication E-Mailed
Feb 3, 2017
Approved For Pub - Principal Register
Feb 3, 2017
Examiner's Amendment Entered
Feb 3, 2017
Notification Of Examiners Amendment E-Mailed
Feb 3, 2017
Examiners Amendment E-Mailed
Feb 3, 2017
Examiners Amendment -Written
Jan 12, 2017
Teas/Email Correspondence Entered
Jan 12, 2017
Correspondence Received In Law Office
Jan 12, 2017
Teas Response To Office Action Received
Dec 23, 2016
Notification Of Non-Final Action E-Mailed
Dec 23, 2016
Non-Final Action E-Mailed
Dec 23, 2016
Non-Final Action Written
Dec 21, 2016
Assigned To Examiner
Nov 10, 2016
New Application Office Supplied Data Entered In Tram
Nov 10, 2016
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
